文献速递特殊人群用药

常规医疗数据中识别重大先天畸形的算法:系统综述

Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review.
PubMed 文献 · Drug Saf · 2025-09-13

本系统综述检索2010年1月1日至2025年4月11日研究,总结美国、加拿大和欧洲常规医疗数据中识别重大先天畸形(MCM)的算法。初检2242项研究,最终纳入289项;算法在数据源类型、地理区域、编码规则及母婴记录使用上存在异质性,仅27项(9.3%)为验证研究,多数阳性预测值>70%。

要点

  • 纳入研究中58.1%来自欧洲,其中80.4%使用北欧国家登记数据。
  • 55.7%的研究通过婴儿出生后第一年收集MCM。
  • 仅9.3%为验证研究,多数阳性预测值>70%但随MCM类型或解剖部位变化。

核心结论

  • 首次系统综述常规医疗数据中识别MCM的算法,算法在编码、规则、母婴记录使用和编码系统上因数据源和地区而异。
  • 验证研究较少,多数阳性预测值>70%,但随MCM类型或解剖部位变化。

研究设计与样本

  • 系统文献综述,检索2010年1月1日至2025年4月11日相关研究,初检2242项,最终纳入289项。
  • 研究筛选和数据提取由两人重复进行,使用标准化数据收集表。

主要发现

  • 58.1%的纳入研究来自欧洲,其中80.4%(N=135)使用北欧国家登记数据。
  • 使用理赔数据的研究占18.0%,使用医院出院数据的研究占16.3%。
  • 55.7%的研究通过婴儿出生后第一年收集MCM。
  • 27项(9.3%)为验证研究,其中70.4%仅基于理赔和/或电子健康记录数据。
  • 多数验证研究的阳性预测值>70%,但随MCM类型或解剖部位变化。

临床怎么用

  • 临床药师在妊娠安全药物流行病学研究中引用MCM算法时,需注意数据源类型和地理区域带来的异质性。
  • 选择算法时应关注验证状态及阳性预测值是否按MCM类型或解剖部位报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Major congenital malformations (MCMs) are a primary outcome of interest in pregnancy safety studies. OBJECTIVE: This study aimed to identify and summarize algorithms used to identify MCMs in routinely collected healthcare data sources in the USA, Canada, and Europe by conducting a systematic literature review. METHODS: We developed a search strategy to identify studies containing algorithms for MCMs from January 1, 2010, to April 11, 2025. Search terms included those related to MCMs as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants. Study review and data extraction was conducted in duplicate using a standardized data collection form. RESULTS: Among the initially identified 2242 studies, 974 were selected for full-text review. Of these, 70.3% were excluded, leaving 289 studies. Over half (58.1%) of the included studies were from Europe, predominantly from Nordic countries using national register data (N = 135; 80.4%). Studies using claims (18.0%) or hospital discharge data (16.3%) were also common. Although there was heterogeneity in the timing of MCM assessment, 55.7% of studies collected MCMs through the infant's first year of life. Overall, algorithms varied across data source type and geography in the codes specified, rules, utilization of maternal versus infant records, and coding system. There were 27 (9.3%) validation studies, 70.4% of which were based on claims and/or electronic health record data only. Most had positive predictive values >70%, though this varied according to MCM type or anatomical site. CONCLUSION: We provide the first comprehensive systematic literature review of algorithms used to identify MCMs in routinely collected healthcare data, aiding researchers in their ability to generate reliable evidence in pregnancy safety pharmacoepidemiology.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Jacobson MH, Sabidó M, Afonso AS, et al. Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review. Drug Saf. 2025. PMID: 40944886. doi:10.1007/s40264-025-01606-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。